160 related articles for article (PubMed ID: 37217164)
21. Diagnostic performance of computed tomography and diffusion-weighted imaging as first-line imaging modality according to the International Myeloma Working Group (IMWG) imaging algorithm for monoclonal plasma cell disorders.
Yoon MA; Chee CG; Chung HW; Lee DH; Kim KW
Acta Radiol; 2022 May; 63(5):672-683. PubMed ID: 33853375
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic value of WB-DWI versus
Zhang B; Zhang L; Bian B; Lin F; Zhu Z; Wang J
Indian J Cancer; 2023; 60(3):303-309. PubMed ID: 37787189
[TBL] [Abstract][Full Text] [Related]
23. Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma.
Sachpekidis C; Goldschmidt H; Dimitrakopoulou-Strauss A
Molecules; 2019 Dec; 25(1):. PubMed ID: 31905752
[TBL] [Abstract][Full Text] [Related]
24. ¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.
Dammacco F; Rubini G; Ferrari C; Vacca A; Racanelli V
Clin Exp Med; 2015 Feb; 15(1):1-18. PubMed ID: 25218739
[TBL] [Abstract][Full Text] [Related]
25. Comparison of whole-body DW-MRI with 2-[
Baratto L; Nyalakonda R; Theruvath AJ; Sarrami AH; Hawk KE; Rashidi A; Shen S; States L; Aboian M; Jeng M; Daldrup-Link HE
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1689-1698. PubMed ID: 36717409
[TBL] [Abstract][Full Text] [Related]
26. Prospective Comparison of 18F-Choline Positron Emission Tomography/Computed Tomography (PET/CT) and 18F-Fluorodeoxyglucose (FDG) PET/CT in the Initial Workup of Multiple Myeloma: Study Protocol of a Prospective Imaging Trial.
Mesguich C; Hulin C; Latrabe V; Asselineau J; Bordenave L; Perez P; Hindie E; Marit G
JMIR Res Protoc; 2020 Sep; 9(9):e17850. PubMed ID: 32909953
[TBL] [Abstract][Full Text] [Related]
27. Comparative Performance of Whole-Body MRI and FDG PET/CT in Evaluation of Multiple Myeloma Treatment Response: Systematic Review and Meta-Analysis.
Rama S; Suh CH; Kim KW; Durieux JC; Ramaiya NH; Tirumani SH
AJR Am J Roentgenol; 2022 Apr; 218(4):602-613. PubMed ID: 34704461
[No Abstract] [Full Text] [Related]
28. Guidelines for the use of imaging in the management of patients with myeloma.
Chantry A; Kazmi M; Barrington S; Goh V; Mulholland N; Streetly M; Lai M; Pratt G;
Br J Haematol; 2017 Aug; 178(3):380-393. PubMed ID: 28677897
[TBL] [Abstract][Full Text] [Related]
29. Pictorial review of whole body MRI in myeloma: emphasis on diffusion-weighted imaging.
Hameed M; Sandhu A; Soneji N; Amiras D; Rockall A; Messiou C; Wallitt K; Barwick TD
Br J Radiol; 2020 Nov; 93(1115):20200312. PubMed ID: 32667830
[TBL] [Abstract][Full Text] [Related]
30. Interobserver agreement of whole-body magnetic resonance imaging is superior to whole-body computed tomography for assessing disease burden in patients with multiple myeloma.
Lai AYT; Riddell A; Barwick T; Boyd K; Rockall A; Kaiser M; Koh DM; Saffar H; Yusuf S; Messiou C
Eur Radiol; 2020 Jan; 30(1):320-327. PubMed ID: 31267214
[TBL] [Abstract][Full Text] [Related]
31. Prospective Evaluation of Whole-Body MRI versus FDG PET/CT for Lesion Detection in Participants with Myeloma.
Messiou C; Porta N; Sharma B; Levine D; Koh DM; Boyd K; Pawlyn C; Riddell A; Downey K; Croft J; Morgan V; Stern S; Cheung B; Kyriakou C; Kaczmarek P; Winfield J; Blackledge M; Oyen WJG; Kaiser MF
Radiol Imaging Cancer; 2021 Sep; 3(5):e210048. PubMed ID: 34559006
[TBL] [Abstract][Full Text] [Related]
32. Multi-parametric whole-body MRI evaluation discerns vital from non-vital multiple myeloma lesions as validated by
Heidemeier A; Schloetelburg W; Thurner A; Metz C; Heidemeier H; Rasche L; Martin Kortuem K; Boeckle D; Weiland E; Benkert T; Nickel D; Werner R; Buck AK; Bley TA
Eur J Radiol; 2022 Oct; 155():110493. PubMed ID: 36027759
[TBL] [Abstract][Full Text] [Related]
33. Prospective Evaluation of Magnetic Resonance Imaging and [
Moreau P; Attal M; Caillot D; Macro M; Karlin L; Garderet L; Facon T; Benboubker L; Escoffre-Barbe M; Stoppa AM; Laribi K; Hulin C; Perrot A; Marit G; Eveillard JR; Caillon F; Bodet-Milin C; Pegourie B; Dorvaux V; Chaleteix C; Anderson K; Richardson P; Munshi NC; Avet-Loiseau H; Gaultier A; Nguyen JM; Dupas B; Frampas E; Kraeber-Bodere F
J Clin Oncol; 2017 Sep; 35(25):2911-2918. PubMed ID: 28686535
[TBL] [Abstract][Full Text] [Related]
34. Multiple Myeloma Guidelines and Their Recent Updates: Implications for Imaging.
Mosebach J; Thierjung H; Schlemmer HP; Delorme S
Rofo; 2019 Nov; 191(11):998-1009. PubMed ID: 31137045
[TBL] [Abstract][Full Text] [Related]
35. Whole-body diffusion-weighted magnetic resonance imaging (WB-DW-MRI) vs choline-positron emission tomography-computed tomography (choline-PET/CT) for selecting treatments in recurrent prostate cancer.
Conde-Moreno AJ; Herrando-Parreño G; Muelas-Soria R; Ferrer-Rebolleda J; Broseta-Torres R; Cozar-Santiago MP; García-Piñón F; Ferrer-Albiach C
Clin Transl Oncol; 2017 May; 19(5):553-561. PubMed ID: 27796820
[TBL] [Abstract][Full Text] [Related]
36. Updates and Ongoing Challenges in Imaging of Multiple Myeloma:
Wu F; Bernard S; Fayad LM; Ilaslan H; Messiou C; Moulopoulos LA; Mulligan ME
AJR Am J Roentgenol; 2021 Oct; 217(4):775-785. PubMed ID: 33978464
[TBL] [Abstract][Full Text] [Related]
37. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C
Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
[TBL] [Abstract][Full Text] [Related]
38. What Is the Comparative Ability of 18F-FDG PET/CT, 99mTc-MDP Skeletal Scintigraphy, and Whole-body MRI as a Staging Investigation to Detect Skeletal Metastases in Patients with Osteosarcoma and Ewing Sarcoma?
Aryal A; Kumar VS; Shamim SA; Gamanagatti S; Khan SA
Clin Orthop Relat Res; 2021 Aug; 479(8):1768-1779. PubMed ID: 33635285
[TBL] [Abstract][Full Text] [Related]
39. Current concepts in tumor imaging with whole-body MRI with diffusion imaging (WB-MRI-DWI) in multiple myeloma and lymphoma.
Stecco A; Buemi F; Iannessi A; Carriero A; Gallamini A
Leuk Lymphoma; 2018 Nov; 59(11):2546-2556. PubMed ID: 29431555
[TBL] [Abstract][Full Text] [Related]
40. Therapy Response Assessment of Pediatric Tumors with Whole-Body Diffusion-weighted MRI and FDG PET/MRI.
Theruvath AJ; Siedek F; Muehe AM; Garcia-Diaz J; Kirchner J; Martin O; Link MP; Spunt S; Pribnow A; Rosenberg J; Herrmann K; Gatidis S; Schäfer JF; Moseley M; Umutlu L; Daldrup-Link HE
Radiology; 2020 Jul; 296(1):143-151. PubMed ID: 32368961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
